Cargando…
Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major challenges for health systems. In this study, we analyzed the effects of better population blood pressure control in the context of a proposed 80-80-80 target: 80% of individuals with hypertension are screened and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388375/ https://www.ncbi.nlm.nih.gov/pubmed/35851877 http://dx.doi.org/10.1038/s41591-022-01890-4 |
_version_ | 1784770215377108992 |
---|---|
author | Pickersgill, Sarah J. Msemburi, William T. Cobb, Laura Ide, Nicole Moran, Andrew E. Su, Yanfang Xu, Xinpeng Watkins, David A. |
author_facet | Pickersgill, Sarah J. Msemburi, William T. Cobb, Laura Ide, Nicole Moran, Andrew E. Su, Yanfang Xu, Xinpeng Watkins, David A. |
author_sort | Pickersgill, Sarah J. |
collection | PubMed |
description | As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major challenges for health systems. In this study, we analyzed the effects of better population blood pressure control in the context of a proposed 80-80-80 target: 80% of individuals with hypertension are screened and aware of their diagnosis; 80% of those who are aware are prescribed treatment; and 80% of those on treatment have achieved guideline-specified blood pressure targets. We developed a population CVD model using country-level evidence on CVD rates, blood pressure levels and hypertension intervention coverage. Under realistic implementation conditions, most countries could achieve 80-80-80 targets by 2040, reducing all-cause mortality by 4–7% (76–130 million deaths averted over 2022–2050) and slowing the rise in CVD expected from population growth and aging (110–200 million cases averted). Although populous middle-income countries would account for most of the reduced CVD cases and deaths, low-income countries would experience the largest reductions in disease rates. |
format | Online Article Text |
id | pubmed-9388375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93883752022-08-20 Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes Pickersgill, Sarah J. Msemburi, William T. Cobb, Laura Ide, Nicole Moran, Andrew E. Su, Yanfang Xu, Xinpeng Watkins, David A. Nat Med Article As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major challenges for health systems. In this study, we analyzed the effects of better population blood pressure control in the context of a proposed 80-80-80 target: 80% of individuals with hypertension are screened and aware of their diagnosis; 80% of those who are aware are prescribed treatment; and 80% of those on treatment have achieved guideline-specified blood pressure targets. We developed a population CVD model using country-level evidence on CVD rates, blood pressure levels and hypertension intervention coverage. Under realistic implementation conditions, most countries could achieve 80-80-80 targets by 2040, reducing all-cause mortality by 4–7% (76–130 million deaths averted over 2022–2050) and slowing the rise in CVD expected from population growth and aging (110–200 million cases averted). Although populous middle-income countries would account for most of the reduced CVD cases and deaths, low-income countries would experience the largest reductions in disease rates. Nature Publishing Group US 2022-07-18 2022 /pmc/articles/PMC9388375/ /pubmed/35851877 http://dx.doi.org/10.1038/s41591-022-01890-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Pickersgill, Sarah J. Msemburi, William T. Cobb, Laura Ide, Nicole Moran, Andrew E. Su, Yanfang Xu, Xinpeng Watkins, David A. Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
title | Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
title_full | Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
title_fullStr | Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
title_full_unstemmed | Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
title_short | Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
title_sort | modeling global 80-80-80 blood pressure targets and cardiovascular outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388375/ https://www.ncbi.nlm.nih.gov/pubmed/35851877 http://dx.doi.org/10.1038/s41591-022-01890-4 |
work_keys_str_mv | AT pickersgillsarahj modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT msemburiwilliamt modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT cobblaura modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT idenicole modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT moranandrewe modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT suyanfang modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT xuxinpeng modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes AT watkinsdavida modelingglobal808080bloodpressuretargetsandcardiovascularoutcomes |